News&Events

NEWS

ALL EVENTS NEWS
NEWS

A feature article on our collaborator, Dr. Tadashi Watabe, Specially Appointed Associate Professor at the Institute for Radiation Sciences, the University of Osaka, has been published in Nikkei Biotechnology.

NEWS

Our collaborator, Dr. Tadashi Watabe, Specially Appointed Associate Professor at the Institute for Radiation Sciences, the University of Osaka, delivered a lecture at a webinar hosted by IBA.

NEWS

Interview articles featuring our collaborator, Dr. Tadashi Watabe, Specially Appointed Associate Professor at the Institute for Radiation Sciences, the University of Osaka, were published in The Chugoku Shimbun and The Niigata Nippo.

NEWS

Our collaborator, Dr. Tadashi Watabe, Specially Appointed Associate Professor at the Institute for Radiation Sciences, the University of Osaka, has received the JNM Best Paper Award for Clinical Investigation.

NEWS

Our collaborator, Dr. Tadashi Watabe, Specially Appointed Associate Professor at the Institute for Radiation Sciences, the University of Osaka, delivered an invited talk at the 2026 SNMMI Annual Meeting held in Los Angeles.

NEWS

Head of Drug Discovery Strategy Kimura has published articles in Medical Science Digest, The Cell (Monthly Journal “Saibou”), and Pharmacia.

NEWS

New Clinical Trial of af-001 for Differentiated Thyroid Cancer Posted on ClinicalTrials.gov

NEWS

Head of Supply Chain Development Kohno delivered a presentation at the Luncheon Seminar of the 3rd Symposium on Short-Lived RIs Application and Research

NEWS

Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Differentiated Thyroid Cancer

NEWS

A clinical trial report on the investigator-initiated Alpha-T1 study by our collaborator, Associate Professor/Lecturer Dr. Watabe from the University of Osaka Graduate School of Medicine, was published in The Journal of Nuclear Medicine.

NEWS

A clinical trial report on the investigator-initiated Alpha-T1 study by our collaborator, Associate Professor/Lecturer Dr. Watabe from the University of Osaka Graduate School of Medicine, was published in The Journal of Nuclear Medicine.

NEWS

Head of Supply Chain Development Kohno presented and participated in a panel discussion at the 6th VC Consortium Special Event

NEWS

Alpha Fusion Inc. Selected for the 2025 Japan–U.S. Innovation Awards Innovation Showcase

NEWS

Alpha Fusion, Inc. and Curadh MTR, Inc. to Enter into Strategic Partnership to Advance Global Development of Astatine-211 Based Radiopharmaceuticals

NEWS

Alpha Fusion Initiates Joint Research with Mitsubishi Tanabe Pharma and Veneno Technologies

NEWS

Head of Research and Development Tomura delivered an invited lecture at The 2nd Short-Lived Radioisotope Research Symposium.

NEWS

Head of Drug Discovery Strategy Kimura delivered a Lecture at the 2nd (36th) Process Chemistry East Shikoku Forum

NEWS

Alpha Fusion Accelerates Astatine-based Drug Discovery with Series B Funding

NEWS

Business Briefing Held at Osaka University TAT Cyclotron Building

NEWS

Initiation of Clinical Trial Using Astatine for Refractory Prostate Cancer

1-20/23

PREV
NEXT